Bryan Tagge, MD
Otolaryngology · Salt Lake City, UTNPI 1164557583
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.1% of the total across 50 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 12 manufacturers, the largest accounting for just 17.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $267, 2.5 times the $105 reported in 2019. That places this record below the midpoint for otolaryngology clinicians in UT, where the typical reported total is $1,304.
Across 50 payments — averaging $20.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Optinose US, Inc.$186
- GSK$177
- Smith+Nephew$120
- Regeneron Healthcare Solutions, Inc.$106
- Sanofi$103
- Stryker$93
- plus $255 from 6 others
What the payments were for
- Food & beverage$97894%
- Education$616%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Optinose US, Inc. | 10 | $186 |
| GSK | 10 | $177 |
| Smith+Nephew | 6 | $120 |
| Regeneron Healthcare Solutions, Inc. | 5 | $106 |
| Sanofi | 5 | $103 |
| Stryker | 3 | $93 |
| Aerin Medical Inc. | 4 | $88 |
| Intersect ENT, Inc. | 3 | $54 |
| Innovation Technologies Inc | 1 | $49 |
| Nexus CMF, LLC | 1 | $26 |
| AbbVie | 1 | $20 |
| Amgen | 1 | $18 |
How this compares
$1,040 in reported general payments places this provider in the 45th percentile of 104 otolaryngology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 129 | $2,904 |
| Mupirocin | 61 | $655 |
| Fluticasone Propionate | 29 | $433 |
| Mometasone Furoate | 27 | $426 |
| Omeprazole | 19 | $392 |
| Montelukast Sodium | 27 | $247 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 26 | $180 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 15 | $108 |
| Naproxen | 11 | $48 |
| Prednisone | 13 | $40 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Salt Lake City
- Steven MillerSalt Lake City$32K
- Michael WilsonSalt Lake City$16K
- Matthew DahlSalt Lake City$12K
- Anthony SanchezSalt Lake City$7K
- Pramod SharmaSalt Lake City$5K
- Joshua BradleySalt Lake City$3K
- Allison DurhamSalt Lake City$3K
- Cory FulcherSalt Lake City$3K
- Mitchell DunklebargerSalt Lake City$2K
- Daniel BestourousSalt Lake City$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.